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SUMMARY – Atopic dermatitis (AD) is a chronic relapsing, inflammatory skin disease. Fa-
ilure to treat AD successfully can often be directly linked to poor treatment adherence as a result 
of the lack of information about the disease and basic principles of treatment. Several studies have 
found that making patients active participants in their care through information and education is a 
successful treatment strategy in AD. The aim of this study was to evaluate parental knowledge on 
AD and to stress the importance of therapeutic educational program in long term management and 
control of the disease. We carried out a short questionnaire-based study among 238 parents of chil-
dren with AD regarding their knowledge on the etiology and treatment of AD. Our results showed 
that 21% of the participants reported corticophobia and were concerned about systemic absorption 
affecting the child’s growth and development even after short application. In children with AD who 
have food hypersensitivity, 14% of parents thought that a small amount of food allergen could be 
beneficial in achieving tolerability. The role of interdisciplinary educational program is to explain 
the epidemiology and pathogenesis of AD, as well as concomitant atopy related diseases and to teach 
parents about the importance of appropriate skin care.
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Introduction
Atopic dermatitis (AD) of childhood is a common 
inflammatory skin disease affecting 15%-20% of pedi-
atric population under the age of 5 and its prevalence 
has markedly increased over the past three decades. 
Its early onset in infancy and chronic relapsing course 
puts special burden on their families1. Children with 
AD often have behavioral problems such as increased 
dependency, fearfulness and sleep difficulties2. Sup-
porting parents in dealing with the management of 
AD presents a challenge for physicians1. Educational 
programs for parents and patients with AD have been 
established in the last ten years in different European 
countries3-6. 
Standardized interdisciplinary programs involving 
dermatologists, pediatricians, psychologists and dieti-
tians improve symptoms and clinical manifestations 
of AD by optimizing the use of medications result-
ing in better compliance and leading to a significant 
increase in the quality of life (QoL)7. The role of the 
interdisciplinary educative program is to explain the 
epidemiology and pathogenesis of AD and allergy 
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related problems (diagnostic, diet, food and respira-
tory allergy) and to teach parents about appropriate 
atopic skin care. Atopic skin care includes the use of 
gentle skin cleaning products, application of adequate 
amounts of corticosteroid ointment and emollients, 
resulting in reduced requirement for corticosteroids. 
Demonstration of the ‘wet wrap’ technique is an ef-
fective method to achieve rapid control of AD and has 
significantly reduced the need of hospitalization. ‘Wet 
wrapping’ involves the application of a weak topical 
corticosteroid or just emollient under an inner wet and 
outer dry layer of cotton tubular bandages or garment. 
Educational approach focusing on topical treatment is 
a major step in cases where topical treatment is either 
misunderstood or conducted erroneously due to fear 
from corticosteroids, therefore having direct implica-
tion on compliance8. 
Topical corticophobia, defined as a non-rational 
fear from using topical corticosteroids, is very common 
in AD9. The duration of topical steroid use required to 
induce perioral dermatitis varies among individuals; 
only a few weeks of application of even mid-strength 
or mild topical steroid can result in typical perioral 
dermatitis, whereas in some patients it develops after 
years of topical steroid application10. Although skin 
thinning and systemic effects occasionally develop, 
the concern expressed by people using corticoster-
oids is out of proportion in relation to the evidence of 
harm. Educational program offers better information 
and education of patients regarding the safety, poten-
cy and appropriate use of topical corticosteroids11. 
Avoiding the causal food proteins leads to clini-
cal improvement, but requires a great deal of educa-
tion because most of the common food allergens (egg, 
milk, wheat, soya bean and peanut) are ubiquitous in 
the food supply, and any elimination diet may lead to 
the risk of nutritional deficits. The role of psychologist 
is to give information about sleeping problems and 
behavioral techniques to deal with it, as well as pro-
posing alternative strategies to eliminate the ‘vicious 
circle’ of itching and scratching lesions with practi-
cal ways of improving the parents’ capacity to face the 
disease related problems12. 
It is important to underline that the aim of educa-
tional program is to improve parents’ knowledge on 
AD, resulting in better understanding of the disease 
by encouraging active treatment approach of the af-
fected individuals and their family members13. A re-
cent German study has reported that age related edu-
cational programs for the control of AD in children 
and adolescents are significantly more effective in the 
long term management of the disease than conven-
tional treatment approach8. 
Finally, patient education has been shown to con-
tribute effectively to preventing complications and 
improving QoL and treatment adherence for numer-
ous chronic illnesses, such as diabetes, asthma, and 
cardiovascular disease14.
Subjects and Method 
The aim of this study was to evaluate parental 
knowledge about AD and to stress the importance of 
the therapeutic educational program in the long term 
management and control of the disease. We carried 
out a short questionnaire-based study in 238 parents of 
children with AD aged 3 months to 6 years in relation 
to treatment approach and knowledge on AD, and to 
assess the prevalence of topical corticosteroid phobia. 
A short questionnaire comprising 10 questions was ad-
ministered to parents of children with AD treated at 
outpatient dermatology departments in two university 
hospitals and one private dermatology clinic.
The questionnaire included 10 different questions 
covering the main different aspects of AD, e.g., the 
etiology of AD, the influence of heredity on the occur-
rence of AD, the risk of other atopic disease associa-
tion, understanding the use of corticosteroids and the 
problem of corticophobia, the possible different associ-
ated symptoms of AD, knowledge about topical immu-
nomodulators, the importance of the elimination diet 
in AD, understanding different treatment modalities 
in AD, and the importance of appropriate skin care. 
In this paper, four selected question results are 
presented regarding the knowledge of the parents 
about topical corticosteroids and immunomodulators, 
the cause of the disease, and the importance of the 
elimination diet in AD. 
Results 
Topical steroids are currently the mainstay of treat-
ment of AD, but prolonged usage can result in skin 
atrophy and some other rare side effects. Our results 
revealed that there was pronounced corticophobia 
among patients and that a significant proportion of 
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parents worried about using topical corticosteroids on 
their child’s skin; 21% of them were concerned about 
the risk of skin atrophy after short application and 
10% of parents considered topical corticosteroids to 
be extremely dangerous and they were worried about 
systemic absorption affecting the growth and devel-
opment of their child. On the other hand, only 1% 
of respondents thought that corticosteroids could be 
used without restriction in quantity and length of ap-
plication, whereas 78% of parents reported that topi-
cal corticosteroids could be administered without side 
effects if the quantity and duration of treatment was 
controlled by dermatologists (Fig. 1). 
The pathogenesis of AD is unknown, but the dis-
ease seems to result from genetic susceptibility, im-
mune dysfunction and epidermal barrier dysfunction. 
In our study, only 32% of parents perceived that the 
basis of AD etiology lied in pronounced constitutional 
hypersensitivity to various allergens, 7% of parents be-
lieved that allergy to specific food (most often to egg 
and cow’s milk) was the cause of AD, while 5% of par-
ents thought that the cause was the child’s impaired 
immunity. The majority of participants thought AD to 
result from all the above mentioned causes (Fig. 2). 
In children with AD and concomitant food hyper-
sensitivity, 14% of parents had wrong impression that a 
small amount of specific food allergen could be given 
in order to achieve tolerability, while 1% thought that 
it was not necessary for a breastfeeding mother to be 
on elimination diet. The majority of participants (64%) 
thought it was important to completely avoid food to 
which a child is hypersensitive and that a breastfeeding 
mother should be on allergen free diet (Fig. 3). 
Topical immunomodulators influence the immune 
system in the skin by altering the action of T cells that 
play an important role in eczema and are currently 
recommended as second-line treatment if eczema has 
not been controlled adequately with topical steroids, or 
where there is a risk of side effects from further steroid 
use. These agents provide effective treatment without 
causing skin atrophy and other steroid side effects15. 
In our study, 71% of parents had no knowledge on 
topical immunomodulators in the treatment of AD. 
Our results showed that two percent of parents thought 
that topical immunomodulators were poorly effective 
and very expensive, and another 2% of them worried 
that these agents could cause skin cancer, while 4% 
of parents thought that topical immunomodulators 
could completely replace topical corticosteroids; 21% 
of parents were well informed that topical immuno-
modulators could be used over a long period without 
steroid side effects (Fig. 4).
Fig. 4. For topical immunomodulators is true that:
Fig. 1. For topical corticosteroids is true that: 
Fig. 2. The cause of atopic dermatitis is: 
Fig. 3. For children who are hypersensitive to certain food 
it is important to: 
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Discussion
The study by Staab et al. has clearly shown that 
educational program for the management of AD in 
parents and children greatly improved control of the 
disease8. Poor treatment adherence is the main rea-
son for treatment failure in patients with AD, with 
the lack of knowledge on AD and its treatment being 
the most important cause16. A comparative Australian 
study demonstrated that moderate or severe AD had 
a more significant impact on families than insulin de-
pendent diabetes mellitus17. 
Patients with AD and their caregivers have several 
educational needs that must be met to take control of 
the disease. They need to understand the chronic and 
relapsing nature of the disease with no cure at pres-
ent, but also that it can be managed effectively. They 
need to be taught how best to apply topical treatment 
and to be motivated to continue treatment, albeit usu-
ally in a modified form when the disease is in remis-
sion. Topical treatment of the child with AD requires 
active approach of the whole family, while informa-
tion given to the parents during appointment with 
the doctor has been found insufficient and further 
consultations are necessary in order to help, both the 
child and the family, understand the disease. Topical 
corticosteroids remain the mainstay of AD therapy, 
but many therapeutic failures appear to result from 
poor treatment compliance due to topical corticoster-
oid phobia, which is common in the management of 
chronic inflammatory skin diseases, AD in particular. 
Sometimes this also leads to patients being exposed 
to the risks of other potentially more dangerous and, 
in many cases, unproven treatments. ‘Herbal’ and 
‘natural’ treatments are often incorrectly assumed to 
be safe. Some ‘herbal’ creams actually contain illegal 
amounts of steroids, sometimes super-potent steroids 
that should not be used in young children. Patients 
and especially parents of small children need to be 
educated about the safety and efficacy of topical corti-
costeroids and their use18. 
In the study by Charman et al., 24% of patients 
refused the use of topical steroids11, and in another 
study by Aubert-Wastiaux et al., 11 years later, 36% 
of patients refused topical steroid application19. In our 
study, 21% of AD patients felt uncertain about using 
topical steroid preparations and had little knowledge 
about their side effects. Therefore, we can conclude 
that proper education of patients will improve effi-
cacy of treatment and patient compliance. Particular 
emphasis should be placed on disease management 
including the use of emollients, controlled use of topi-
cal steroids with teaching of ‘fingertip unit’ and ‘wet 
wrap’ bandages.
The main advantage of topical immunomodulators 
is that they carry no risk of skin thinning at all, and 
so they can be used on any part of the body includ-
ing delicate areas such as the face, eyelids, elbows and 
creases, where they work particularly well. Further-
more, there is no restriction of the length of time the 
treatments can be used. They are also very effective in 
maintaining control of AD once it has been brought 
under control15. Our study showed that there was poor 
knowledge about topical immunomodulators, as 71% 
of parents had never heard about these agents. 
Therapeutic patient education in the form of 
‘Atopic Dermatitis School’ improves patient/parent-
physician contact, clinical visits are shorter, and there 
is improved treatment compliance and less concern 
about using topical steroids3. Our approach focuses on 
practical management of the disease, and information 
on its etiology, epidemiology, clinical features and 
complications, particularly infections and exacerbat-
ing factors including allergens. Our study highlights 
the need of providing better information and edu-
cation of patients and possibly general practitioners 
regarding the safety, potency and appropriate use of 
topical corticosteroids.
From December 2011 to September 2014, we or-
ganized a structured multidisciplinary educational 
program at Clinical Department of Dermatovenere-
oloy, Sestre milosrdnice University Hospital Center. 
This educational program was offered to the parents 
of children with AD once a month and covered all 
important information on the etiology, epidemiol-
ogy, prevention and treatment of AD, as well as on 
nutritional and psychological problems important in 
daily practice. It was carried out by a multiprofession-
al team consisting of a dermatologist, psychologist 
and dietitian. The participants were given handouts 
summarizing the timetable and the most important 
points of the sessions. The sessions also encouraged 
participants to share personal experiences and to try 
out newly learned skills.
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Conclusion
Lack of information, overstrain, helplessness, 
and lack of confidence in medical treatment lead to 
suboptimal management of the disease and increase 
the use of healthcare resources, including alternative 
therapies. Patient education has been regarded as hav-
ing a key role in the self-management of AD. Unlike 
taking an oral medication, education is essential for 
the correct use of topical treatment. The aim of edu-
cational program is to improve parents’ knowledge on 
AD, resulting in better understanding of the disease 
by encouraging active treatment approach of the af-
fected individuals and their family members. In order 
to improve the quality of life of children and families 
affected by AD, we offered an interdisciplinary, struc-
tured educational program which covered medical, 
nutritional and psychological aspects of the disease. 
We believe that educational programs of this type, in 
association with conventional treatment, can be use-
ful in the long term management and control of the 
disease. 
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Sažetak
VAŽNOST EDUKACIJSKE INTERVENCIJE I ZNANJA RODITELJA O ATOPIJSKOM DERMATITISU 
KOD DJECE
L. Kotrulja, T. Milavić, S. Ožanić Bulić,  N. Šitum, A. Bakija Konsuo, I. Muršić, I. Birkić Belanović i L. Dilenardo
Atopijski dermatitis (AD) je kronična, recidivirajuća upalna bolest kože. Neuspjeh u liječenju AD može biti izravno 
povezan s neprimjerenim pridržavanjem uputa o provođenju terapije kao posljedica nedostatka informacija o bolesti i 
osnovnim načelima liječenja. Nekoliko studija je utvrdilo da se uspješna strategija u liječenju AD zasniva na aktivnom 
uključenju bolesnika u provođenje skrbi kroz informiranje i edukaciju o bolesti. Cilj ovoga istraživanja bio je procijeniti po-
znavanje problematike AD kod roditelja oboljele djece i naglasiti važnost terapijskog edukacijskog programa u uspješnom 
liječenju i kontroli bolesti. Proveli smo studiju primjenom kratkog upitnika među 238 roditelja djece s AD i mogućnosti-
ma liječenja AD. Naši rezultati su pokazali da 21% sudionika ima izraženu kortikofobiju i strah od sistemske apsorpcije 
koja može utjecati na rast i razvoj djeteta čak i nakon kratkotrajne primjene kortikosteroida. Kod djece s AD koja imaju 
dokazanu preosjetljivost na hranu 14% roditelja mislilo je da mala količina alergena u hrani može biti korisna u postizanju 
podnošljivosti. Uloga interdisciplinarnog obrazovnog programa je objasniti epidemiologiju i patogenezu AD, kao i poprat-
nu problematiku atopijskih bolesti i poučavati roditelje o njezi atopijske kože. 
Ključne riječi: Dermatitis, atopijski; Roditelji – edukacija; Bolesnik, edukacija (kao tema); Kortikosteroidi – terapijska primje-
na; Fobični poremećaji – psihologija; Dijete; Liječenje, odbijanje – psihologija; Liječenje, neuspješno; Bolesnik, suradljivost
